Latest filing published 06 Jul 2017 for Rein Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Excel Medical Fund LP: trading record in brief
Filings by Excel Medical Fund LP span 2 companies, the busiest being Rein Therapeutics, Inc. and Tetraphase Pharmaceuticals Inc. In total, 4 filings cover trades dated from 25 March 2013 to 5 July 2017.
The open-market record is one-sided, with 2 purchases worth €3.5M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2017: 1 purchase and no sales on the market.
The newest entry dates from 6 July 2017: a transaction, in Rein Therapeutics, Inc. The most recent open-market purchase was published on 6 July 2017, 3,413 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Excel Medical Fund LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 956,100 sharesCommon StockSEC:0000899243-17-018010:0
- 60,000 shares@ US$15.00Common StockSEC:0000899243-17-018010:1Canonical exit: 3 Oct 2017 (T+90)
- 496,121 shares@ US$7.00Common StockSEC:0001181431-13-019223:1Canonical exit: 23 Jun 2013 (T+90)
- 972,384 sharesCommon StockSEC:0001181431-13-019223:0
4 of 4 declarations
